4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($1.01) EPS for the quarter, missing the consensus estimate of ($0.97) by ($0.04), Zacks reports. The company had revenue of $3.05 million during the quarter, compared to analysts’ expectations of $2.59 million. 4D Molecular Therapeutics had a [...]
4D Molecular Therapeutics (NASDAQ:FDMT) Announces Quarterly Earnings Results
